Experimental and clinical evidence suggests that impaired postprandial insulin release and dysregulated appetite control in obesity could partly be due to defective GLP1 secretion and action [11,12,13]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.